Merck CEO Rob Davis on Q2 results: We continue to see phenomenal growth CNBC Television 6:07 1 year ago 3 251 Скачать Далее
Merck CEO Robert Davis on earnings: We have strong momentum across key growth drivers CNBC Television 3:37 1 year ago 3 043 Скачать Далее
Merck CEO on Winrevair Approval, Obesity Drug, Health Costs Bloomberg Television 5:53 4 months ago 3 291 Скачать Далее
Merck CEO on Covid Pill Distribution, Vaccine Development Bloomberg Television 5:41 2 years ago 157 819 Скачать Далее
Merck stock up on Q2 earnings beat, Pfizer revenue declines on falling COVID vaccine demand Yahoo Finance 3:09 1 year ago 1 806 Скачать Далее
Merck beats earnings expectations, raises sales outlook on strong demand for top drugs like Keytruda CNBC Television 0:39 2 weeks ago 807 Скачать Далее
Immunic CEO discusses Q2 results & MS trials update Proactive Investors 4:05 9 days ago 508 Скачать Далее
Cervical Cancer Vaccination: All You Need to Know About the Cervical Cancer Vaccine (HPV Vaccine) Judith Evaare-Tom 8:02 1 year ago 98 Скачать Далее
GlobalFoundries Q2FY24 Earnings - Episode 227 - Six Five Podcast Moor Insights & Strategy 10:04 8 days ago 541 Скачать Далее
Merck Stock Analysis for Rest of 2021 | Merck Stock To Skyrocket? Capital.com. Stocks 8:49 2 years ago 913 Скачать Далее
Merck on track to deliver 3.1 million Covid pill courses to U.S. soon, CEO says CNBC Television 2:48 2 years ago 1 262 Скачать Далее
Jim Cramer on Ken Frazier's legacy as CEO of Merck CNBC Television 4:23 3 years ago 3 216 Скачать Далее
Marqeta CEO on Q2 earnings, consumer trends and the end of cash CNBC Television 5:40 8 days ago 844 Скачать Далее
Johns Hopkins Health Policy Forum with Merck CEO Robert M. Davis - October 4, 2021 Johns Hopkins University 46:30 2 years ago 1 785 Скачать Далее
Is Merck & Co Inc (MRK) a Stock to Watch After Losing -1.91% This Week? Market News - Short & Sweet 1:19 10 months ago 18 Скачать Далее
TSMC Q2FY24 Earnings - Episode 224 - Six Five Podcast Moor Insights & Strategy 8:26 4 weeks ago 3 619 Скачать Далее
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales CNBC Television 1:13 3 months ago 693 Скачать Далее
Bringing AR/VR to Life: How Merck's Expertise is Leading the Way Merck 1:53 1 year ago 117 Скачать Далее
Merck Research Labs - Yash discusses his motivation to join Merck Merck Careers 1:00 2 years ago 157 Скачать Далее
Safety of BCA101, an EGFR/TGFβ inhibitor, with pembrolizumab in HNSCC VJOncology 1:52 1 year ago 103 Скачать Далее